[{"uuid": "6fbc2f86-61e9-3484-aa9a-9911295f7453", "title": "Dogwood Therapeutics Announces Patient Dosing in Phase 2b Trial Evaluating Halneuron\u00ae in Patients with Chemotherapy Induced Neuropathy (CINP) to Commence First Quarter of 2025", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/dogwood-therapeutics-announces-patient-dosing-141500897.html", "providerPublishTime": 1737468900, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/BTWcVaEQDxqj4DA08V9Gqw--~B/aD0xMjAwO3c9MTIwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/c2211ba4f734687fc25eeda327f9138e", "width": 1200, "height": 1200, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/DMynLWSqE_w36rWjmogZwg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/c2211ba4f734687fc25eeda327f9138e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DWTX"]}, {"uuid": "b27253c5-85eb-3e13-9a51-f644370ca4ad", "title": "DWTX: Phase 2 Long COVID Results Expected Soon", "publisher": "Zacks Small Cap Research", "link": "https://finance.yahoo.com/news/dwtx-phase-2-long-covid-120000545.html", "providerPublishTime": 1731326400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ahe8sAh5rRO7CUqbbjc14Q--~B/aD00NzY7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/scr.zacks.com/a4a4aa377f6485673a808043343455e6", "width": 620, "height": 476, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/gLRU.kf.kYROHSm6YdrrXQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/a4a4aa377f6485673a808043343455e6", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DWTX"]}, {"uuid": "961d66b1-3ecd-30c1-b902-e6a81407afce", "title": "Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/wall-street-set-open-mixed-141139098.html", "providerPublishTime": 1735049499, "type": "STORY"}, {"uuid": "58667da1-989d-3b97-998d-128d5ddd13a1", "title": "Dogwood Therapeutics Announces Third Quarter 2024 Financial Results", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/dogwood-therapeutics-announces-third-quarter-120500828.html", "providerPublishTime": 1730981100, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/BTWcVaEQDxqj4DA08V9Gqw--~B/aD0xMjAwO3c9MTIwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/c2211ba4f734687fc25eeda327f9138e", "width": 1200, "height": 1200, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/DMynLWSqE_w36rWjmogZwg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/c2211ba4f734687fc25eeda327f9138e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DWTX"]}, {"uuid": "4759c438-2117-3a5c-96ec-98ee6a851b79", "title": "Dogwood Therapeutics Inc (DWTX) Q3 2024 Earnings Call Highlights: Strategic Financing and ...", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/dogwood-therapeutics-inc-dwtx-q3-071536186.html", "providerPublishTime": 1731050136, "type": "STORY", "relatedTickers": ["DWTX"]}, {"uuid": "8bd176ed-1baa-3b37-9fd3-5b71641c76ce", "title": "Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/dogwood-therapeutics-inc-announces-low-134500650.html", "providerPublishTime": 1731937500, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/BTWcVaEQDxqj4DA08V9Gqw--~B/aD0xMjAwO3c9MTIwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/c2211ba4f734687fc25eeda327f9138e", "width": 1200, "height": 1200, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/DMynLWSqE_w36rWjmogZwg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/c2211ba4f734687fc25eeda327f9138e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DWTX"]}, {"uuid": "35149e10-615f-3917-bee1-dd9ae8aabdc0", "title": "Top Premarket Decliners", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/top-premarket-decliners-124932835.html", "providerPublishTime": 1731329372, "type": "STORY", "relatedTickers": ["DWTX", "VMAR"]}, {"uuid": "026c576e-e120-3d8b-bfd5-c65b4a9af795", "title": "Q3 2024 Dogwood Therapeutics Inc Earnings Call", "publisher": "Thomson Reuters StreetEvents", "link": "https://finance.yahoo.com/news/q3-2024-dogwood-therapeutics-inc-073543786.html", "providerPublishTime": 1731051343, "type": "STORY", "relatedTickers": ["DWTX"]}]